Promoting Excellence in Education, Research,
and Patient Care in the Rapidly Evolving
Management of Gastrointestinal Cancer
International Society of
Gastrointestinal Oncology
isgioEstablished 2003

2012 Gastrointestinal Oncology Conference Review

2012 Gastrointestinal Oncology Conference
September 13-15, 2012 - Arlington, VA

Please click on abstract title to review abstract PDF file (opens in a new window).

Esophageal Cancer
Chemotherapy Alone is an Appropriate Preoperative Therapy for Locally Advanced Esophageal Cancer
Hope E. Uronis
Duke University Medical Center, Durham, NC
Chemotherapy and Radiotherapy are Necessary Preoperative Therapy
David H. Ilson
Memorial Sloan-Kettering Cancer Center, New York, NY
CT-Based Assessment of Visceral Adiposity and Outcomes for Esophageal Adenocarcinoma
Saeed NA
Moffitt Cancer Center, Department of Gastrointestinal Oncology
Phase II Trial of Sorafenib in Esophageal (E) and Gastroesophageal Junction (GEJ) Cancer: Response Observed in Adenocarcinoma
E. Won
Memorial Sloan-Kettering Cancer Center, New York, NY
Pancreatic Cancer
Borderline Resectable Pancreatic Cancer
Jason B. Fleming
MD Anderson Cancer Center, Houston, TX

Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.
David Z. Chang
MD Anderson Cancer Center
Houston, TX

Advanced Colorectal Cancer
Use of Anti-EGFR Antibodies in First-Line Therapy of Metastatic CRC
Howard S. Hochster
Professor of Medicine, Yale Cancer Center, New Haven, CT
Asian Approach to Advanced Colorectal Cancer (First-Line)
Kohei Shitara
National Cancer Center Hospital East, Chiba, Japan
Maintenance Therapy With Biologics
Johanna Bendell
Sarah Cannon Research Institute, Nashville, Tennessee
Aflibercept vs Placebo in Combination With FOLFIRI After Failure of an Oxaliplatin-Based Regimen for Metastatic Colorectal Cancer: North American Results of a Multinational Phase III Trial (EFC10262-VELOUR)
Edith P. Mitchell
Hot Topics in Gastrointestinal Oncology
Inflammation and Gastric Caner: Helicobacter pylori
Juanita L. Merchant
University of Michigan, Ann Arbor, Michigan
Neuroendocrine Tumors (NET)
Molecular Markers, Molecular Signatures and Treatment Decision in Stage II Colon Cancer
Daniel Sargent
Mayo Clinic, Rochester, MN
Japanese Perspectives on Adjuvant Chemotherapy for Colorectal Cancer
Nozomu Fuse
National Cancer Center Hospital East, Kashiwashi, Chiba, Japan
New therapeutic possibilities of combined treatment of radiotherapy with cisplatin, oxaliplatin or their liposomal formulations (Lipoplatin and Lipoxal) in colorectal cancer using nude mouse xenograft
Thititip Tippayamontria
Department of Nuclear Medicine and Radiobiology
Hepatobiliary Cancer
Update on the Pathologic Classification and Grading of NETs
David S. Klimstra
Memorial Sloan-Kettering Cancer Center, New York, New York
Esophageal/Gastric Cancer
Esophageal Cancer: A Study on an Unusual Case of Recurrence Occurring Five Years After Initial Chemo-Radiation Therapy and Related Literature Review
Hong Chin, Reba Cowell
Dayton VA Medical Center, Dayton, OH
Relationship between Late Radiotherapy toxicity after pelvic cancers
Bhavna Gami
The GI Unit
Autologous Cell Therapy with Induced Pluripotent Stem Cells (iPSCs) Encoded with Anti-GRP78 shRNA Induces Apoptosis After a Gene-Silencing Bystander Effect Circumventing Angiogenesis, and Metastatic Spread in Advanced Gastrointestinal Stromal Tumors (GIST)
John N Giannios
Univ of Varna, International Society of Molecular and Genomic Medicine
Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel Combined with Oral S-1 for Gastric Cancer with Peritoneal Metastasis
Joji Kitayama, Hironori Ishigami, Hironori Yamaguchi, Shigenobu Emoto, Toshiaki Watanabe
University of Tokyo, Tokyo, Japan
Audit Attempting to Identify Factors Which May Predict Failed Resection of Oesophago-Gastric Cancer Operations
Emilie Nicholls
ZT (NHS Lancashire Teaching Trust), EN (NHS Lancashire Teaching Trust), PT (NHS Lancashire Teaching Trust), KGP (NHS Lancashire Teaching Trust), JBW (NHS Lancashire Teaching Trust)
Pancreatic Cancer
A Pilot Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil and Radiation Therapy in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma
Cetin V
UMass Memorial Medical Center, Worcester, Massachusetts
Pathophysiology of Pancreatic Cancer in Patients over 80 Years of Age
Cuervo L, Song J, Ashley P, Wajima T, Wong L
Scott & White Healthcare/Texas A&M University Health Science Center, Temple, Texas, USA.
Recurrent Pulmonary Embolism Resulting in Sudden Death as the Presenting Symptom of Periampullary Duodenal Adenocarcinoma
Basile Njei, Harold Sanchez
University of Connecticut, Farmington, CT
Advanced Colon Cancer
Epigenomic Treatment with LNA-Modified Oligonucleotides Targeting mRNA of DICER via PEG-Nanosomes with Linked Abs Against CD44 on Cancer Stem Cells (CSCs) and Metastatic Colorectal Ca (mCRC) Induces PCD Type-I and a Bystander Killing Effect (BKE) After Dual Inhibition of Epigenetic Oncomirs Which Interferes with Genomic Pathways that Downregulate Antiapoptotic Coding and Noncoding Oncogenes by Interacting with Their 3'UTRs, and Demethylation of CpG Islands Leading to Activation of Apoptotic Tumor Suppressor Nnonprotein Coding Genes and miRNAs
J. Giannios, K. Ivanov, K. Metodiev
Dept of Translational Medicine, Medical University of Varna, EU

Efficacy and Safety of Regorafenib in Previously Treated Metastatic Colorectal Cancer (mCRC) – Results of the Randomized, Placebo-Controlled, Phase 3 CORRECT Trial
Axel Grothey
Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA

The Value of Tumor M2-Pyruvate Kinase in Stomach Cancer Screening
Dae Young Cheung, Jung Ho Kim, Tae Ho Kim, Sung Soo Kim, Jin Il Kim, Jae Kwang Kim
Department of Internal Medicine, the Catholic University of Korea College of Medicine, Seoul, Korea
The Role of Perfusion Computed Tomography in Assessment of Spatial and Temporal Vascular Heterogeneity in Rectal Cancers
Aftab Khan
Department of Gastrointestinal Research, Mount Vernon Cancer Treatment and Research Centre,
Northwood, Greater London, UK
Combined Fecal Transferrin Test and Immuno Fecal Occult Blood Test for Detecting Colorectal Cancer and Advanced Adenoma in Asymptomatic and Symptomatic Populations
Peng Jin
Department of Gastroenterology, Beijing Military General Hospital, Beijing, People’s Republic of China
Above-label doses of octreotide-LAR in patients with metastatic small intestinal carcinoid tumors
Jonathan Strosberg, Jill Weber, Max Feldman, Larry Kvols
H. Lee Moffitt Cancer Center, 12902 Magnolia Dr. Tampa FL
Long-term, Open-label Everolimus in Patients With Pancreatic Neuroendocrine Tumors: Two Case Presentations From RADIANT-3
Edward M. Wolin
Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA